Log in
Enquire now
‌

US Patent 9308213 Solid solution compositions and use in chronic inflammation

Patent 9308213 was granted and assigned to infirst Healthcare on April, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
infirst Healthcare
Current Assignee
‌
infirst Healthcare
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9308213
Patent Inventor Names
Robin M. Bannister4
John Brew4
Richard R. Reiley, III4
Wilson Caparros Wanderley4
Date of Patent
April 12, 2016
Patent Application Number
14155108
Date Filed
January 14, 2014
Patent Citations Received
‌
US Patent 11660276 Compositions and methods for treating chronic inflammation and inflammatory diseases
1
‌
US Patent 11992555 Solid solution compositions and use in chronic inflammation
2
‌
US Patent 11918654 Solid solution compositions and use in severe pain
3
‌
US Patent 11744812 Methods of treatment
Patent Primary Examiner
‌
Kevin E. Weddington
Patent abstract

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9308213 Solid solution compositions and use in chronic inflammation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.